Newsroom

Newsroom

NeoGenomics Schedules its Q2 2017 Earnings Release for July 25, 2017

Press Release
Read More

Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor-mutated essential thrombocythemia

Literature
Read More

Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits

Literature
Read More

An APL Case without a Detectable RARA Gene Rearrangement

Literature
Read More

BRAF mutation and PD-L1 expression in melanoma: Comparison between multiple PD-L1 IHC clones and BRAF mutation evaluated by FDA-approved kits versus NGS

Literature
Read More

Expression of PD-L1 in colorectal cancer that lack mutations in RAS or TP53 genes

Literature
Read More

NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests

Press Release
Read More

NeoGenomics Reports that its NeoLAB® Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients